Taffic Tablet is a prescription combination medicine containing Bictegravir, Emtricitabine, and Tenofovir Alafenamide, used for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection in eligible patients. This advanced antiretroviral therapy helps reduce viral load, support immune system function, and improve long-term health outcomes when taken as prescribed. Taffic works by blocking HIV replication at different stages of the viral life cycle, helping maintain effective viral suppression. It is an important part of modern HIV treatment and should be used under medical supervision. Taffic Tablets are available for bulk purchase through authorized pharmaceutical suppliers and healthcare distributors.